MacroGenics, Inc. (MGNX) vs Q32 Bio Inc. (QTTB)

A side-by-side comparison of MacroGenics, Inc. and Q32 Bio Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — MGNX vs QTTB

growth of $100 · dividends reinvested · last 9y
MGNX -86.5% (-20.0%/yr)QTTB -97.5% (-33.7%/yr)MGNX compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $1002020202220242026$13$2
MGNX QTTB

MGNX vs QTTB: by the numbers

  • •QTTB is the larger company ($241M vs $233M market cap).
  • •QTTB is profitable (62.87% net margin) while MGNX runs a net loss (-8.70%).
  • •QTTB grew revenue faster over the past five years (10.22% vs 7.33% CAGR).

Metrics side by side

Valuation

MetricMGNXQTTB
P/E ratioN/A2.91
P/S ratio1.394.49
P/B ratio5.442.28
EV / EBITDAN/A6.40

Profitability

MetricMGNXQTTB
Gross margin71.12%99.84%
Operating margin-48.72%31.45%
Net margin-8.70%62.87%
ROE-34.04%31.90%
ROIC-16.87%19.43%

Growth (annualized)

MetricMGNXQTTB
Revenue CAGR (5Y)7.33%10.22%
Total return CAGR (5Y)-28.42%-41.51%

Frequently asked

Which has grown faster, MGNX or QTTB?
Over the past five years, QTTB grew revenue faster — MGNX at a 7.33% CAGR versus QTTB at 10.22%.
Is MGNX or QTTB more profitable?
QTTB runs the higher net margin — MGNX at -8.70% versus QTTB at 62.87%.
How have MGNX and QTTB total returns compared?
Over the past 5 years, MGNX delivered -28.42% and QTTB delivered -41.51% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.